Feng Chi Biotech Corp. (TPEX:6744)
Taiwan · Delayed Price · Currency is TWD 14.00
0.00 (0.00%)
Aug 18, 2026, 11:17 AM CST
Feng Chi Biotech Market Cap
Feng Chi Biotech has a market cap or net worth of 215.6 million as of August 18, 2026. Its market cap has decreased by -22.22% in one year.
Market Cap
215.60M
Enterprise Value
47.79M
Revenue
156.99M
Ranking
n/a
PE Ratio
21.59
Stock Price
14.00
ChartMarket Cap Chart
Since September 25, 2019, Feng Chi Biotech's market cap has decreased from 742.28M to 215.60M, a decrease of -70.95%. That is a compound annual growth rate of -16.40%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 18, 2026 | 215.60M | -21.35% |
| Dec 31, 2025 | 274.12M | -10.10% |
| Dec 30, 2024 | 304.92M | -10.81% |
| Dec 29, 2023 | 341.88M | 11.00% |
| Dec 29, 2022 | 308.00M | -19.19% |
| Dec 28, 2021 | 381.15M | -16.10% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Sep 25, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Taiwan Advance Bio-Pharmaceutical | 822.60M |
| NatureWise Biotech & Medicals | 786.46M |
| BioLASCO Taiwan | 760.68M |
| SynCore Biotechnology Co.,Ltd | 683.95M |
| MegaPro Biomedical | 656.92M |
| Neith | 633.14M |
| Vectorite Biomedical | 569.03M |
| TaiwanJ Pharmaceuticals | 548.84M |